Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2025-12-24 @ 11:49 PM
NCT ID:
NCT01570751
Eligibility Criteria:
Inclusion Criteria:
* Type 2 diabetes
* Current treatment with once daily insulin glargine in vials with a daily dose equal to or above 65 U and equal to or below 100 U
* Current treatment with a stable dose of metformin plus/minus one additional oral antidiabetic drug (OAD) for at least 12 weeks
* Glycosylated haemoglobin (HbA1c) equal to or above 7.5%
Exclusion Criteria:
* Current treatment with insulin other than insulin glargine in vials
* Treatment with thiazolidinediones or glucagon-like peptide-1 (GLP-1) receptor agonists within 12 weeks
* Stroke; heart failure; myocardial infarction; unstable angina pectoris; coronary arterial bypass graft or angioplasty
* Suffer from cancer (except basal cell skin cancer and squamous-cell cancer)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01570751
Study Brief:
Protocol Section:
NCT01570751